Sabal Trust CO Eli Lilly & CO Transaction History

Sabal Trust CO

$1.68 Billion
Q2 2024

A detailed history of Sabal Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Sabal Trust CO holds 5,435 shares of LLY stock, worth $4.84 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

5,435

Previous 5,413 0.41%

Holding current value

$4.84 Million

Previous $4.21 Million 16.84%

% of portfolio

0.29%

Previous 0.24%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $15,947 - $19,998	22 Added 0.41%	5,435 $4.92 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $198,387 - $265,413	335 Added 6.6%	5,413 $4.21 Million
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $247,364 - $291,610	-471 Reduced 8.49%	5,078 $2.96 Million
Q2 2023 Jul 20, 2023	BUY	$350.74 - $468.98 $91,893 - $122,872	262 Added 4.96%	5,549 $2.6 Million
Q1 2023 Apr 26, 2023	SELL	$310.63 - $364.82 $38,828 - $45,602	-125 Reduced 2.31%	5,287 $1.82 Million
Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $89,712 - $104,532	279 Added 5.44%	5,412 $1.98 Million
Q3 2022 Oct 18, 2022	BUY	$296.48 - $337.87 $32,019 - $36,489	108 Added 2.15%	5,133 $1.66 Million
Q2 2022 Jul 18, 2022	BUY	$278.73 - $327.27 $20,068 - $23,563	72 Added 1.45%	5,025 $1.63 Million
Q1 2022 Apr 14, 2022	SELL	$234.69 - $291.66 $210,282 - $261,327	-896 Reduced 15.32%	4,953 $1.42 Million
Q4 2021 Jan 21, 2022	SELL	$224.85 - $279.04 $26,082 - $32,368	-116 Reduced 1.94%	5,849 $1.62 Million
Q3 2021 Oct 18, 2021	BUY	$221.6 - $272.71 $110,800 - $136,355	500 Added 9.15%	5,965 $1.38 Million
Q2 2021 Jul 16, 2021	SELL	$180.55 - $233.54 $8,124 - $10,509	-45 Reduced 0.82%	5,465 $1.25 Million
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $248,780 - $322,058	-1,514 Reduced 21.55%	5,510 $1.03 Million
Q4 2020 Jan 20, 2021	SELL	$130.46 - $172.63 $3,391 - $4,488	-26 Reduced 0.37%	7,024 $1.19 Million
Q3 2020 Oct 14, 2020	SELL	$146.22 - $169.13 $40,210 - $46,510	-275 Reduced 3.75%	7,050 $1.04 Million
Q2 2020 Jul 13, 2020	SELL	$136.42 - $164.18 $40,925 - $49,254	-300 Reduced 3.93%	7,325 $1.2 Million
Q1 2020 Apr 14, 2020	BUY	$119.05 - $147.35 $72,144 - $89,294	606 Added 8.63%	7,625 $1.06 Million
Q4 2019 Jan 14, 2020	SELL	$106.92 - $132.43 $52,604 - $65,155	-492 Reduced 6.55%	7,019 $923,000
Q3 2019 Oct 15, 2019	BUY	$106.79 - $116.16 $40,153 - $43,676	376 Added 5.27%	7,511 $840,000
Q2 2019 Jul 17, 2019	SELL	$110.79 - $129.32 $32,683 - $38,149	-295 Reduced 3.97%	7,135 $790,000
Q1 2019 Apr 12, 2019	SELL	$111.31 - $131.02 $48,419 - $56,993	-435 Reduced 5.53%	7,430 $964,000
Q4 2018 Feb 01, 2019	BUY	$105.9 - $118.64 $79,425 - $88,980	750 Added 10.54%	7,865 $911,000
Q3 2018 Oct 16, 2018	BUY	$85.86 - $107.31 $15,884 - $19,852	185 Added 2.67%	7,115 $764,000
Q2 2018 Jul 16, 2018	BUY	$75.7 - $86.88 $24,981 - $28,670	330 Added 5.0%	6,930 $591,000
Q1 2018 Apr 16, 2018	SELL	$74.21 - $87.6 $25,231 - $29,783	-340 Reduced 4.9%	6,600 $511,000
Q4 2017 Feb 07, 2018	BUY	$81.94 - $87.89 $40,970 - $43,945	500 Added 7.76%	6,940 $586,000
Q3 2017 Oct 17, 2017	BUY	$77.07 - $85.54 $496,330 - $550,877	6,440	6,440 $551,000

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $847B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabal Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sabal Trust CO with notifications on news.

Account